HR Execs on the Move

Imaging Healthcare Specialists

www.imaginghealthcare.com

 
Imaging Healthcare Specialists is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

American Arthritis and Osteoporosis

American Arthritis & Osteoporosis Care Center owned and operated by Shereen Hashmi, M.D.

Pursuant Health

Empowering the public through free, convenient self-service health care. Formerly SoloHealth.

Millenium Laboratories

Millennium Laboratories, a leader in the science of toxicology and pharmacogenetics, is transforming the way health care providers improve clinical outcomes. Millennium helps practitioners provide personalized care to patients in need through its patient-centered research and education initiatives and its ability to respond to evolving health care challenges with advanced technologies.

Cigna Global Health

Everything we do is around our mission to help you improve your health, wellbeing and peace of mind. We have extensive experience in managing varied and unique clinical and service situations worldwide. Our vast experience, coupled with our expertise, enables us to provide high standards of healthcare coverage, regardless of where you are in the world. Cigna International by the numbers: • Our international health insurance plans give you access to a global network of over 1.5 million hospitals, clinics and doctors. • Our employees serve over 160 million customers in key markets around the globe. • Our Customer Care Team is here for you 24/7, 365 days a year.

Alector

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.